Amalgamated Bank’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.06M Buy
51,334
+1,018
+2% +$86.5K 0.03% 529
2026
Q1
$4.33M Buy
50,316
+527
+1% +$47.3K 0.03% 470
2025
Q4
$4.35M Sell
49,789
-1,926
-4% -$146K 0.03% 475
2025
Q3
$2.96M Sell
51,715
-150
-0.3% -$8.64K 0.02% 644
2025
Q2
$3.06M Sell
51,865
-207
-0.4% -$13.4K 0.02% 613
2025
Q1
$3.81M Sell
52,072
-1,712
-3% -$141K 0.03% 480
2024
Q4
$4.45M Sell
53,784
-56
-0.1% -$4.42K 0.04% 432
2024
Q3
$3.85M Sell
53,840
-3,053
-5% -$216K 0.03% 503
2024
Q2
$3.9M Sell
56,893
-6,720
-11% -$401K 0.03% 545
2024
Q1
$3.41M Sell
63,613
-11,180
-15% -$601K 0.03% 654
2023
Q4
$3.99M Sell
74,793
-4,064
-5% -$198K 0.03% 600
2023
Q3
$3.92M Buy
78,857
+27,092
+52% +$1.51M 0.03% 566
2023
Q2
$3.08M Sell
51,765
-2,760
-5% -$157K 0.02% 683
2023
Q1
$3.09M Sell
54,525
-1,904
-3% -$122K 0.03% 680
2022
Q4
$4.19M Buy
56,429
+1,002
+2% +$68.2K 0.04% 577
2022
Q3
$3.3M Sell
55,427
-1,166
-2% -$70.2K 0.03% 598
2022
Q2
$3.18M Buy
56,593
+514
+0.9% +$33.8K 0.03% 665
2022
Q1
$4.14M Sell
56,079
-1,713
-3% -$119K 0.03% 577
2021
Q4
$4.17M Buy
57,792
+1,040
+2% +$75.5K 0.03% 608
2021
Q3
$4.35M Sell
56,752
-5,361
-9% -$430K 0.04% 583
2021
Q2
$4.82M Buy
62,113
+52,687
+559% +$3.75M 0.04% 572
2021
Q1
$581K Sell
9,426
-617
-6% -$39.1K 0.02% 899
2020
Q4
$655K Buy
10,043
+192
+2% +$11K 0.02% 805
2020
Q3
$488K Sell
9,851
-43
-0.4% -$2.22K 0.02% 849
2020
Q2
$472K Sell
9,894
-4,411
-31% -$213K 0.02% 869
2020
Q1
$608K Sell
14,305
-484
-3% -$23.9K 0.01% 819
2019
Q4
$871K Buy
14,789
+673
+5% +$36.5K 0.02% 864
2019
Q3
$722K Sell
14,116
-218
-2% -$10.4K 0.02% 879
2019
Q2
$606K Buy
14,334
+2,533
+21% +$110K 0.01% 975
2019
Q1
$583K Buy
11,801
+383
+3% +$17.3K 0.01% 934
2018
Q4
$494K Buy
11,418
+6,420
+128% +$320K 0.01% 930
2018
Q3
$284K Sell
4,998
-6,686
-57% -$352K 0.01% 1149
2018
Q2
$590K Buy
11,684
+1,531
+15% +$79.8K 0.01% 937
2018
Q1
$506K Sell
10,153
-184
-2% -$8.65K 0.01% 954
2017
Q4
$425K Buy
10,337
+616
+6% +$21.6K 0.01% 1078
2017
Q3
$289K Sell
9,721
-441
-4% -$13.5K 0.01% 1233
2017
Q2
$337K Buy
10,162
+511
+5% +$16.1K 0.01% 1128
2017
Q1
$286K Sell
9,651
-12
-0.1% -$328 0.01% 1164
2016
Q4
$240K Buy
+9,663
New +$220K 0.01% 1279

Other funds holding GMED

Amalgamated Bank's GMED Position: Q2 2026 in Review

Amalgamated Bank increased its Globus Medical (GMED) stake by 2% in Q2 2026, buying an estimated $86.5K and bringing the position to 51,334 shares worth $4.06M. The position accounts for 0.03% of the portfolio, ranked #529.

Amalgamated Bank first reported a position in GMED in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.82M in Q2 2021. 295 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Amalgamated Bank held 51,334 shares of Globus Medical worth $4.06M as of Q2 2026.
  • Amalgamated Bank bought 1,018 Globus Medical shares in Q2 2026, an estimated $86.5K.
  • Globus Medical made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #529 holding.
  • Amalgamated Bank first reported a position in Globus Medical in Q4 2016 and has held it in 39 quarters since.
  • Amalgamated Bank's Globus Medical position peaked at $4.82M in Q2 2021.
  • 295 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.